Category: Obstetrics/Gynecology
Obstetrics/Gynecology market research reports by GlobalData
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region ... Read More
-
Uterine Leiomyoma: Competitive Landscape
Uterine Leiomyoma: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Uterine Leiomyoma therapeutics. In 2024, more than 16 million incident cases of UL are anticipated in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
Dysmenorrhea: Competitive Landscape
Dysmenorrhea: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Dysmenorrhea therapeutics. In 2024, more than 647 million diagnosed prevalent cases of DM are anticipated in the 16 countries covered in GlobalData’s epidemiolo ... Read More
-
Fetal Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Fetal Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Fetal Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulato ... Read More
-
Reproductive Hormones and Proteins Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Reproductive Hormones and Proteins Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Reproductive Hormones and Proteins Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative ... Read More
-
Female Infertility: Seven-Market Drug Forecast and Market Analysis
Female Infertility: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Female infertility market through 2033. GlobalData estimates that the value of the female infertilit ... Read More
-
Female Infertility: Epidemiology Forecast to 2033
Female Infertility: Epidemiology Forecast to 2033 Summary Infertility is a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 or more months of regular unprotected sexual intercourse (Zegers-Hochschild et al., 2009; Mascarenhas et al., 2012; Mayo Clini ... Read More
-
Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape
Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PCOS therapeutics. More than 54,000,000 total prevalent cases of PCOS are expected in 2024 in the 16 countries covered in GlobalData’s ep ... Read More
-
Female Sexual Dysfunction (FSD) - Competitive Landscape
Female Sexual Dysfunction (FSD) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FSD therapeutics. More than 384,000,000 total prevalent cases of FSD were there in 2023 in the 16 countries covered in GlobalData’s epidemio ... Read More
-
Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Regi ... Read More
-
Endometriosis - Global Clinical Trials Review, 2024
Endometriosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Endometriosis - Global Clinical Trials Review, 2024 provides an overview of Endometriosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Re ... Read More
-
Premature Labor (PL) -Competitive Landscape
Premature Labor (PL) -Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PL therapeutics. More than 5,000,000 total prevalent cases of PL are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology foreca ... Read More
-
Ovarian Cancer Opportunity Assessment and Forecast
Ovarian Cancer Opportunity Assessment and Forecast Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 7MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Ovarian Cancer. These sales fo ... Read More
-
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize qu ... Read More
-
Cervical Cancer - Global Clinical Trials Review, 2024
Cervical Cancer - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Cervical Cancer - Global Clinical Trials Review, 2024 provides an overview of Cervical Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Ca ... Read More
-
Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Female Contraceptives market throu ... Read More
-
Bacterial Vaginosis (BV) - Competitive Landscape
Bacterial Vaginosis (BV) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in BV therapeutics. More than 248 million total prevalent cases of BV are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
Menopausal Disorders (MD) - Competitive Landscape
Menopausal Disorders (MD) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MD therapeutics. More than 208 million total prevalent cases of MD are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiolog ... Read More
-
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 U ... Read More
-
Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Endometriosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Updat ... Read More
-
Spain Reproductive Health Procedures Count by Segments and Forecast to 2030
Spain Reproductive Health Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Spain Reproductive Health Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain Reproductive Health Procedures. The databook report provides procedure ... Read More
-
Mexico Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Mexico Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Mexico Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Mexico Reversible Contraceptive Procedures. The databook report ... Read More
-
Russia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Russia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Russia Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Russia Reversible Contraceptive Procedures. The databook report ... Read More
-
Japan Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
Japan Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Japan Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Reversible Contraceptive Procedures. The databook report pro ... Read More
-
South Korea Reversible Contraceptive Procedures Count by Segments and Forecast to 2030
South Korea Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “South Korea Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the South Korea Reversible Contraceptive Procedures. The d ... Read More
Research Assistance
